This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Nihon Kohden Corporation. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: The Innovative Mind of Yoshitaka Amano
Introduction
Yoshitaka Amano is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of medical diagnostics, particularly in tumor detection. His innovative approach combines advanced technology with practical applications in healthcare.
Latest Patents
Amano holds a patent for a method and apparatus for diagnosing a tumor using a histogram and excluding abnormal fluorescence corresponding to DNA aneuploidy. This invention provides a sophisticated apparatus and method for diagnosing tumors. The process involves generating a histogram from the fluorescence intensity of a suspension produced from a target sample. The histogram illustrates the relationship between fluorescence intensity and the number of cells. A determination section detects an S phase fluorescence intensity range corresponding to S phase cells and identifies an abnormal fluorescence intensity range linked to tumor cells. This method allows for accurate tumor diagnosis by analyzing the number of cells while excluding abnormal fluorescence.
Career Highlights
Yoshitaka Amano is associated with Nihon Kohden Corporation, a leading company in the medical technology sector. His work has been instrumental in advancing diagnostic techniques that enhance patient care and treatment outcomes.
Collaborations
Amano has collaborated with notable colleagues, including Takahiro Shioyama and Akane Suzuki. Their combined expertise has contributed to the development of innovative solutions in medical diagnostics.
Conclusion
Yoshitaka Amano's contributions to the field of tumor diagnostics exemplify the impact of innovation in healthcare. His patented methods and collaborative efforts continue to pave the way for advancements in medical technology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
